Robert J. Ife
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
Ion Transport and Channel Regulation, Chemical Synthesis and Analysis, Receptor Mechanisms and Signaling, ATP Synthase and ATPases Research, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor(1999)336 cited
- → 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)(2001)160 cited
- → The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2(2003)130 cited
- → 5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)(2003)107 cited
- → 5-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)(2003)106 cited
- → CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach(2003)95 cited
- → SB-656104-A: A novel 5-HT7 receptor antagonist with improved In vivo properties(2002)73 cited
- → Studies on the mechanism of action of omeprazole(1985)73 cited
- → Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogs of 4-(arylamino)quinolines(1990)58 cited